{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:18:36Z","timestamp":1760746716134,"version":"build-2065373602"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04392-1","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T10:45:06Z","timestamp":1760697906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multisystemic manifestations of a rare Glu89Lys (p. Glu109Lys) transthyretin amyloidosis: a case report of an East Asian female"],"prefix":"10.1186","volume":"25","author":[{"given":"Linhuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houshi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"9","key":"4392_CR1","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/jnnp-2014-308724","volume":"86","author":"Y Sekijima","year":"2015","unstructured":"Sekijima Y. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry. 2015;86(9):1036\u201343.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4392_CR2","doi-asserted-by":"crossref","unstructured":"Porcari A, Fontana M, Gillmore JD. Transthyretin cardiac amyloidosis. Cardiovasc Res. 2023;118(18):3517\u201335.","DOI":"10.1093\/cvr\/cvac119"},{"key":"4392_CR3","doi-asserted-by":"crossref","unstructured":"Monda E, Cirillo C, Verrillo F, et al. Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update. Heart Fail Clin. 2024;20(3):317\u2013323.","DOI":"10.1016\/j.hfc.2024.03.006"},{"key":"4392_CR4","unstructured":"Sekijima Y , Nakamura K, Adam MP, et al. Hereditary Transthyretin Amyloidosis. GeneReviews\u00ae\u00a0. Seattle (WA): University of Washington, Seattle. 1993. 2001 Nov 5. updated 2024 May 30."},{"key":"4392_CR5","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.jacc.2015.09.075","volume":"66","author":"MA Gertz","year":"2015","unstructured":"Gertz MA, Benson MD, Dyck PJ, et al. Diagnosis, prognosis, and therapy of transthyretin amyloidosis. J Am Coll Cardiol. 2015;66:2451\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"4392_CR6","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","volume":"10","author":"V Plante-Bordeneuve","year":"2011","unstructured":"Plante-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol. 2011;10:1086\u201397.","journal-title":"Lancet Neurol"},{"issue":"1","key":"4392_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3109\/13506120009146824","volume":"7","author":"M Nakamura","year":"2000","unstructured":"Nakamura M, Asl KH, Benson MD. A novel variant of transthyretin (Glu89Lys) associated with familial amyloidotic polyneuropathy. Amyloid. 2000;7(1):46\u201350.","journal-title":"Amyloid"},{"issue":"2","key":"4392_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/13506129.2022.2142110","volume":"30","author":"F de Frutos","year":"2023","unstructured":"de Frutos F, Ochoa JP, G\u00f3mez-Gonz\u00e1lez C, et al. Phenotype and clinical outcomes of Glu89Lys hereditary transthyretin amyloidosis: a new endemic variant in Spain. Amyloid. 2023;30(2):199\u2013207.","journal-title":"Amyloid"},{"key":"4392_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-8-31","volume":"8","author":"Y Ando","year":"2013","unstructured":"Ando Y, CoelhO T, Berk JL, et al. Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis. 2013;8:31.","journal-title":"Orphanet J Rare Dis"},{"key":"4392_CR10","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00415-019-09688-0","volume":"268","author":"D Adams","year":"2021","unstructured":"Adams D, Ando Y, Beir\u00e3o JM, et al. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol. 2021;268:2109\u201322.","journal-title":"J Neurol"},{"issue":"1","key":"4392_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13023-019-1000-1","volume":"14","author":"M Waddington-Cruz","year":"2019","unstructured":"Waddington-Cruz M, Schmidt H, Botteman MF, et al. Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series. Orphanet J Rare Dis. 2019;14(1):34.","journal-title":"Orphanet J Rare Dis"},{"key":"4392_CR12","first-page":"156","volume":"183","author":"MM Reynolds","year":"2017","unstructured":"Reynolds MM, Veverka KK, Veverka, Gertz MA, et al. Ocular manifestations of Familial transthyretin amyloidosis. Am J. 2017;183:156\u201362.","journal-title":"Am J"},{"key":"4392_CR13","doi-asserted-by":"crossref","unstructured":"Qin Q , Wei C, Piao Y et al. Current review of leptomeningeal amyloidosis associated with transthyretin mutations. Neurologist. 2021;26(5):189\u201395.","DOI":"10.1097\/NRL.0000000000000337"},{"issue":"8","key":"4392_CR14","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2215\/CJN.08720811","volume":"7","author":"L Lobato","year":"2021","unstructured":"Lobato L, Rocha A. Transthyretin amyloidosis and the kidney. Clin J Am Soc Nephrol. 2021;7(8):1337\u201346.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4392_CR15","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","volume":"73","author":"FL Ruberg","year":"2019","unstructured":"Ruberg FL, Grogan M, Hanna M, et al. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73:2872\u201391.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"4392_CR16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.5603\/CJ.a2020.0104","volume":"29","author":"M Gawor","year":"2022","unstructured":"Gawor M, Holcman K, Franaszczyk M, et al. Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis. Cardiol J. 2022;29(6):985\u201393.","journal-title":"Cardiol J"},{"issue":"6","key":"4392_CR17","first-page":"830","volume":"33","author":"PR Bourque","year":"2017","unstructured":"Bourque PR, ,McCurdy AR, Mielniczuk LM, et al. Cardiac amyloidosis phenotype associated with a Glu89Lys transthyretin mutation. Can J Cardiol. 2017;33(6):830. e5-830. e7.","journal-title":"Can J Cardiol"},{"issue":"6","key":"4392_CR18","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1097\/TP.0b013e318208c0a2","volume":"91","author":"J Niederhauser","year":"2011","unstructured":"Niederhauser J, Lobrinus JA, Ochsner F, et al. Successful heart and liver transplantation in a Swiss patient with Glu89Lys transthyretin amyloidosis. Transplantation. 2011;91(6):e40\u20132.","journal-title":"Transplantation"},{"issue":"3","key":"4392_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/ICB.0b013e31828eefa2","volume":"7","author":"R Sandhu","year":"2013","unstructured":"Sandhu R, Westcott M, Pavesio C, et al. Retinal microangiopathy as an initial manifestation of familial amyloid cardiomyopathy associated with transthyretin e89k mutation. Retin Cases Brief Rep. 2013;7(3):271\u20135.","journal-title":"Retin Cases Brief Rep"},{"issue":"6","key":"4392_CR20","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.02.015","volume":"24","author":"F Salvi","year":"2015","unstructured":"Salvi F, Pastorelli F, Plasmati R, et al. Brain microbleeds 12 years after orthotopic liver transplantation in Val30Met amyloidosis. J Stroke Cerebrovasc Dis. 2015;24(6):e149\u201351.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"6","key":"4392_CR21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1046\/j.1440-1827.2001.01228.x","volume":"51","author":"N Sakashita","year":"2001","unstructured":"Sakashita N, Ando Y, Jinnouchi K, Yoshimatsu M, et al. Familial amyloidotic polyneuropathy (ATTR Val30Met) with widespread cerebral amyloid angiopathy and lethal cerebral hemorrhage. Pathol Int. 2001;51(6):476\u201380.","journal-title":"Pathol Int"},{"issue":"6","key":"4392_CR22","first-page":"6077","volume":"14","author":"X-D Zhang","year":"2017","unstructured":"Zhang X-D, Liu Y-X, Yan\u00a0XW, et, al. Cerebral embolism secondary to cardiac amyloidosis: A case report and literature review. Exp Ther Med. 2017;14(6):6077\u201383.","journal-title":"Exp Ther Med"},{"issue":"1","key":"4392_CR23","doi-asserted-by":"publisher","first-page":"e008193","DOI":"10.1161\/CIRCHEARTFAILURE.120.008193","volume":"15","author":"P Elliot","year":"2021","unstructured":"Elliott P, Drachman BM, Gottlieb SS, et al. Long-term survival with Tafamidis in patients with transthyretin amyloid cardiomyopathy. Circ Heart Fail. 2021;15(1):e008193.","journal-title":"Circ Heart Fail"},{"key":"4392_CR24","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/ene.14285","volume":"27","author":"TH Brannagan","year":"2020","unstructured":"Brannagan TH, Wang AK, Coelho T, Waddington Cruz M, et al. Early data on long-term efcacy and safety of Inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial. Eur J Neurol. 2020;27:1374\u201381.","journal-title":"Eur J Neurol"},{"issue":"1","key":"4392_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S1474-4422(20)30368-9","volume":"20","author":"D Adams","year":"2021","unstructured":"Adams D, Polydefkis M, Gonz\u00e1lez-Duarte A, et al. Long-term safety and efcacy of Patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Lancet Neurol. 2021;20(1):49\u201359.","journal-title":"Lancet Neurol"},{"issue":"7","key":"4392_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1212\/01.wnl.0000267338.45673.f4","volume":"69","author":"V Plant\u00e9-Bordeneuve","year":"2007","unstructured":"Plant\u00e9-Bordeneuve V, Ferreira A, Lalu T, et al. Diagnostic pitfalls in sporadic transthyretin Familial amyloid polyneuropathy (TTRFAP). Neurology. 2007;69(7):693\u20138.","journal-title":"Neurology"},{"issue":"2","key":"4392_CR27","first-page":"152","volume":"83","author":"H Koike","year":"2012","unstructured":"Koike H, Tanaka F, Hashimoto R, et al. Natural history of transthyretin Val30Met Familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. JNNP. 2012;83(2):152\u20138.","journal-title":"JNNP"},{"key":"4392_CR28","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1007\/s00415-013-7124-7","volume":"260","author":"MF Dohrn","year":"2013","unstructured":"Dohrn MF, R\u00f6cken C, De Bleecker JL, et al. Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin related amyloid-neuropathy. J Neurol. 2013;260:3093\u2013108.","journal-title":"J Neurol"},{"issue":"2","key":"4392_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1590\/0004-282x20180156","volume":"77","author":"M Waddington Cruz","year":"2019","unstructured":"Waddington Cruz M, Pinto MV, Pinto LF, et al. Baseline disease characteristics in Brazilian patients enrolled in transthyretin amyloidosis outcome survey (THAOS). Arq Neuropsiquiatr. 2019;77(2):96\u2013100.","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"4392_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13023-025-03589-4","volume":"20","author":"Y P\u00e9r\u00e9on","year":"2025","unstructured":"P\u00e9r\u00e9on Y , Adams D , Camdessanch\u00e9 J-P, et al. Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective study. Orphanet J Rare Dis. 2025;20(1):95.","journal-title":"Orphanet J Rare Dis"},{"issue":"e143","key":"4392_CR31","first-page":"52","volume":"91","author":"P Lozeron","year":"2018","unstructured":"Lozeron P, Mariani L-L, Dodet P, et al. Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy. Neurology. 2018; 91: e143\u201352.","journal-title":"Neurology"},{"issue":"1","key":"4392_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13023-017-0726-x","volume":"13","author":"Y Sekijima","year":"2018","unstructured":"Sekijima Y ,Ueda M, Koike H, et al. Diagnosis and management of transthyretin Familial amyloid polyneuropathy in japan: red-flag symptom clusters and treatment algorithm. Orp J Rare Dis. 2018;13(1):6.","journal-title":"Orp J Rare Dis"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04392-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04392-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04392-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T10:45:09Z","timestamp":1760697909000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04392-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4392"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04392-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"17 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was reviewed and approved by the Institutional Ethics Committee of Shantou Central Hospital. Written informed consent was obtained from the patient for the publication of anonymized clinical details, diagnostic imaging, and laboratory findings. All personal identifiers have been removed to protect the patient\u2019s privacy in accordance with the Declaration of Helsinki and institutional ethical guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of anonymized clinical details, diagnostic imaging, and laboratory findings.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"430"}}